Trade names Cymerin ATC code L01AD07 (WHO) Route Intravenous therapy | Routes of
administration IV Molar mass 327.71 g/mol | |
 | ||
AHFS/Drugs.com International Drug Names Legal status In general: ℞ (Prescription only) Synonyms 1-(2-chloroethyl)-1-nitroso-3-([(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-methoxyoxan-2-yl]methyl)urea | ||
Ranimustine meaning
Ranimustine (INN, marketed under the tradename Cymerin; also known as MCNU) is a nitrosourea alkylating agent approved in Japan for the treatment of chronic myelogenous leukemia and polycythemia vera.
Contents
It has never been filed for FDA evaluation in the United States, where it is not marketed.
What does ranimustine mean
References
Ranimustine Wikipedia(Text) CC BY-SA